A study to assess the relative bioavailability and safety of different formulations of AZD4831 in fasted state in healthy volunteers.

Trial Identifier: D6580C00016
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05457270
Start Date: August 2022
Primary Completion Date: October 2022
Study Completion Date: October 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225